• 103.7k views

“Yes! We can end TB! World Tuberculosis Day “

Tuberculosis is a leading cause of death worldwide, with an estimated 1.5 million deaths in 2020, and is particularly prevalent in low- and middle-income countries. The DOTS (Directly Observed Treatment, Short-Course) regimen is the recommended treatment for tuberculosis (TB) by the World Health Organization (WHO). It is a six-month course of four first-line drugs: Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide. The DOTS regimen is also cost-effective and feasible to implement in resource-limited settings, making it a critical component of global efforts to end TB.

About the Speaker

Dr. Padmanesan Narasimhan Profile Image

Dr. Padmanesan Narasimhan

Digital Health Roster of Experts at World Health Organization

Dr. Padma Narasimhan was awarded the UNSW-University International Postgraduate Scholarship for a PhD at the School. . He is the Deputy Director of the WHO Collaborating Centre for Digital Health at UNSW and is listed as a Roster of Experts in the newly formed WHO Department of Digital Health. His research work has been published widely in leading local and international journals and he currently serves as the section editor for the prestigious PLoS Digital Health journal.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Padmanesan Narasimhan's Talks on Assimilate

webinar
Dr. Padmanesan Narasimhan
  • 24th-March-2023, TIME : 2:00PM - 3:00PM
  • 0

Tuberculosis is a leading cause of death worldwide, with an estimated 1.5 million deaths in 2020, and is particularly prevalent in low- and middle-income countries. The DOTS (Directly Observed Treatment, Short-Course) regimen is the recommended treatment for tuberculosis (TB) by the World Health Organization (WHO). It is a six-month course of four first-line drugs: Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide. The DOTS regimen is also cost-effective and feasible to implement in resource-limited settings, making it a critical component of global efforts to end TB.

webinar
Dr. Padmanesan Narasimhan
  • 24th-March-2023, TIME : 2:00PM - 3:00PM
  • 0

Tuberculosis is a leading cause of death worldwide, with an estimated 1.5 million deaths in 2020, and is particularly prevalent in low- and middle-income countries. The DOTS (Directly Observed Treatment, Short-Course) regimen is the recommended treatment for tuberculosis (TB) by the World Health Organization (WHO). It is a six-month course of four first-line drugs: Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide. The DOTS regimen is also cost-effective and feasible to implement in resource-limited settings, making it a critical component of global efforts to end TB.